Evidence map›Paper›PMID 40716809›Full record

ReviewThe Nursing clinics of North America2025

Overview of the Epidemiology, Diagnosis, and Clinical Care Considerations for People Living with and at Risk for Tuberculosis in the United States.

Alanna Bergman, Tania Thomas

Abstract readReview
In one paragraph

Review in The Nursing clinics of North America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Alanna BergmanSchool of Nursing, University of Virginia, 202 Jeanette Lancaster Way, PO Box 800782, Charlottesville, VA 22903, USA. Electronic address: dhm8ax@virginia.edu.
Tania ThomasDivision of Infectious Diseases and International Health, University of Virginia School of Medicine, University of Virginia, PO Box 801340, Charlottesville, VA 22908-1340, USA.

Funding

Evaluation of novel tuberculosis LAM assays among people living with HIV and sepsisR21AI172637 · NIAID · UNIVERSITY OF VIRGINIA · PI THOMAS, TANIA A · 2022 to 2023
$434k
NIAID NIH HHS R21 AI172637
6 · The paper itself

Abstract

Tuberculosis (TB) remains an ongoing threat. TB requires exposure to Mycobacterium tuberculosis, but disease development is driven by exposure, infectiousness, susceptibility, and environment. TB elimination requires increased awareness about TB prevention and treatment strategies. The centers of TB excellence complement current guidelines from the Center for Disease Control and Prevention, the National TB Coalition of America, and the Infectious Disease Society of America to support nurses and providers. Enhanced contact investigation, prevention, and treatment will aid in the pathway to a TB-free North America. To address disparities in TB, nurses in practice, research, and policy settings must address individual, interpersonal, and organizational barriers to care and ongoing treatment adherence.

Indexed as

TuberculosisHumansRisk FactorsUnited StatesIsolationTBTPTTuberculosis

Identifiers

PMID40716809
PMCPMC12670217

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.